Who Paid My Doc
Non-Covered Product
Drug None
General payments
$7,077,392
Research payments
$513,880,496
Through program year 2020, $7,077,392 in general payments and $513,880,496 in research payments were reported against Non-Covered Product (None).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
4 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2020 | General | $2,650,360 | 883 |
| 2020 | Research | $259,025,433 | 17,570 |
| 2019 | General | $4,427,032 | 3,909 |
| 2019 | Research | $254,855,063 | 17,963 |
Breakdown
The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2020.
The top 5 of 48 specialties; each share is of general payments naming this product to practitioners with a specialty in 2020. Each practitioner is counted under their primary specialty.
The top 5 of 40 states; each share is of general payments naming this product in 2020 where a state was reported.
Records
4,792 general · 35,533 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.